Login / Signup

Reply to Patel et al.: Tempering the Clinical Effects of Early Myeloid-derived Suppressor Cell Expansion in Severe Sepsis and Septic Shock.

Fabrice UhelChristophe CamusArnaud GacouinJean-Marc TadiéYves Le TulzoMikael RousselKarin Tarte
Published in: American journal of respiratory and critical care medicine (2019)
Keyphrases
  • septic shock
  • single cell
  • cell therapy
  • early onset
  • stem cells
  • intensive care unit
  • bone marrow
  • drug induced